HSIF02 · House Subcommittee

Oversight and Investigations Subcommittee

Under Energy and Commerce Committee energycommerce.house.gov

House Energy and Commerce Subcommittee on Oversight and Investigations

Fact sheet Spreadsheet

Showing the 116th Congress (2019–2020). Back to the 119th Congress

0 bills referred in the 116th Congress

1 across the 1 Congress on file, most in the 111th at 1. A referral is not a hearing: most bills sent to a committee are never taken up.

Bills referred, by Congress 111th to 111th

Members
19

Served in the 116th Congress

Meetings
21

Hearings and business meetings in the 116th Congress

Members, 116th Congress 19

Everyone listed on the subcommittee in the 116th Congress, from printed hearings, the Congressional Directory and the official rosters.

Record

Bills, meetings, hearings, reports and more, newest first. In the 116th Congress.

Hearings, markups and business meetings, newest first. In the 116th Congress.

KindSubjectStatusDate
Hearing“Pathway to a Vaccine: Ensuring a Safe and Effective Vaccine People Will Trust” - Virtual Hearing----------
5 witnesses
  • Dr. Helene Gayle, Co-Chair, National Academies of Sciences, Engineering, and Medicine
  • Dr. Ashish Jha, Dean, Brown University
  • Dr. Ali Khan, Dean, University of Nebraska Medical Center
  • Dr. Mark McClellan, Founding Director, Duke University
  • Dr. Paul Offit, Director, Children’s Hospital of Philadelphia
ScheduledSep 30, 2020
Hearing"Pathway to a Vaccine: Efforts to Develop a Safe, Effective and Accessible COVID-19 Vaccine"(Virtual Hearing)
5 witnesses
  • Dr. John Young, Chief Business Officer, Pfizer
  • Dr. Julie Gerberding, Executive Vice President and Chief Patient Officer, Merck
  • Dr. Stephen Hoge, President, Moderna
  • Dr. Mene Pangalos, Executive Vice President, BioPharmaceuticals R&D, AstraZeneca
  • Dr. Macaya Douoguih, Head of Clinical Development and Medical Affairs, Janssen Vaccines, Johnson & Johnson
ScheduledJul 21, 2020
Hearing"On the Front Lines: How Governors are Battling the COVID-19 Pandemic" (Virtual Hearing)
3 witnesses
  • The Honorable Asa Hutchinson, Governor
  • The Honorable Jarad Polis, Governor
  • The Honorable Gretchen Whitmer, Governor
ScheduledJun 2, 2020
HearingIn the Dark: Lack of Transparency in the Live Event Ticketing IndustryRayburn House Office Building 2123
6 witnesses
  • Bryan Perez, Chief Executive Officer, AXS
  • Stephanie Burns, Vice President and General Counsel, StubHub
  • Ryan Fitts, Vice President, Legal Affairs, Vivid Seats
  • Amy Howe, President & Chief Operating Officer, Ticketmaster
  • Don Vaccaro, Co-Founder and Chief Executive Officer, TicketNetwork
  • Joe Choti, President & Chief Executive Officer, Tickets.com
ScheduledFeb 26, 2020
HearingVaping in America: E-Cigarette Manufacturers’ Impact on Public HealthRayburn House Office Building 2123
5 witnesses
  • Ricardo Oberlander, President & CEO, Reynolds American Inc.
  • Ryan Nivakoff, CEO, NJOY, LLC
  • Antoine Blonde, President, Fontem U.S.
  • Jerry Loftin, President, Logic Technology Development, LLC
  • K.C. Crosthwaite, CEO, JUUL Labs, Inc.
ScheduledFeb 5, 2020
HearingA Public Health Emergency: State Efforts to Curb the Opioid CrisisRayburn House Office Building 2123
5 witnesses
  • Nicole Alexander-Scott, M.D., Director, Department of Health, State of Rhode Island
  • Monica Bharel, M.D., Commissioner, Department of Public Health, Commonwealth of Massachusetts
  • Kody Kinsley, Deputy Secretary, Behavioral Health and Intellectual and Developmental Disabilities, State of North Carolina
  • Jennifer Smith, Secretary, Department of Drug and Alcohol Programs, Commonwealth of Pennsylvania
  • Christina Mullins, Commissioner, Bureau for Behavioral Health, State of West Virginia
ScheduledJan 14, 2020
HearingSecuring the U.S. Drug Supply Chain: Oversight of FDA’s Foreign Inspection ProgramRayburn House Office Building 2123
2 witnesses
  • Dr. Mary Denigan-Macauley, Ph.D., Director, Healthcare, Government Accountability Office
  • Dr. Janet Woodcock, M.D., Director, U.S. Food and Drug Administration
ScheduledDec 10, 2019
HearingFlu Season: U.S. Public Health Preparedness and ResponseRayburn House Office Building 2123
4 witnesses
  • Robert Kadlec, M.D., M.T.M.&H., M.S., Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
  • Peter Marks, M.D., Ph.D., Director, U.S. Food and Drug Administration
  • Dr. Anthony Fauci, M.D., Director, National Institutes of Health
  • Dr. Nancy Messonnier, M.D. (CAPT, USPHS, RET), Director, Centers for Disease Control and Prevention
ScheduledDec 4, 2019

By Congress

The committee's record in each Congress on file. Choose one to see the page as it stood then: its members, subcommittees and record. A dash means the official source has nothing that early, not that the committee did nothing.

CongressMembersBills referredBecame lawMeetings
119th2025–2026, sitting200011
118th2023–2024170027
117th2021–2022190017
116th2019–2020190021
115th2017–2018200029
114th2015–2016240020
113th2013–2014270017
112th2011–201225000
111th2009–20102111—
110th2007–20081700—
109th2005–20061600—
108th2003–20041900—
107th2001–20021700—

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

$1 $5 $10

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress. Seats run from the 107th Congress, dated by the resolutions that made them and the Congressional Record; referrals and nominations from the 107th; meetings from the 112th. A committee older than that shows less than it has done. A subcommittee's referrals are recorded against it separately from its parent's, so the two lists do not add up. Records come from Congress.gov, GovInfo and the House and Senate.